HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $736,715 | +12.6% | 6,368 | +0.1% | 0.01% | +16.7% |
| Q2 2023 | $654,434 | -5.3% | 6,363 | +0.5% | 0.01% | -14.3% |
| Q1 2023 | $691,294 | +72.4% | 6,334 | -2.3% | 0.01% | +40.0% |
| Q3 2022 | $401,000 | -94.2% | 6,481 | -92.6% | 0.01% | -91.9% |
| Q2 2022 | $6,940,000 | +47.4% | 87,018 | +94.5% | 0.06% | +72.2% |
| Q1 2022 | $4,707,000 | -39.3% | 44,740 | -37.8% | 0.04% | -37.9% |
| Q4 2021 | $7,749,000 | -38.1% | 71,914 | -37.0% | 0.06% | -27.5% |
| Q3 2021 | $12,509,000 | +108.6% | 114,196 | +78.3% | 0.08% | +53.8% |
| Q2 2021 | $5,996,000 | +10.3% | 64,040 | +8.5% | 0.05% | 0.0% |
| Q1 2021 | $5,434,000 | +44.2% | 59,043 | +13.4% | 0.05% | +33.3% |
| Q4 2020 | $3,768,000 | +383.7% | 52,056 | +419.3% | 0.04% | +290.0% |
| Q3 2020 | $779,000 | +48.7% | 10,025 | +6.4% | 0.01% | +42.9% |
| Q2 2020 | $524,000 | +87.8% | 9,424 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $279,000 | -13.1% | 9,424 | +6.1% | 0.01% | 0.0% |
| Q4 2019 | $321,000 | – | 8,879 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |